Measles Is Spreading Faster Than Any Time in Three Decades
The United States is experiencing a measles crisis that has no modern parallel. As of July 9, 2026, the Centers for Disease Control and Prevention confirmed 2,231 measles cases across 42 jurisdictions — a pace that is set to surpass the full-year 2025 total of 2,289 cases, itself a 33-year record, with five months still remaining in the year.
More revealing than the case count is the driver: 93% of all confirmed 2026 cases involved people who were unvaccinated or whose vaccination status was unknown. Thirty-two separate outbreaks have been confirmed this year, with the summer travel season now underway and large outdoor gatherings increasing the risk of further spread.
The CDC has warned state and local health departments that more cases are anticipated. "With continued measles transmission in areas across North America and expected increases in international and domestic travel and large events during spring and summer, additional measles cases are anticipated in the coming months," the agency said in a formal advisory.
Why This Matters
Measles is one of the most contagious infectious diseases known. According to the CDC, if one infected person enters a room, up to nine out of ten unprotected people nearby will contract the virus. The virus remains viable in the air for up to two hours after an infected person has left the space — meaning exposure can occur without any direct contact.
For vaccinated Americans, the risk is low. Two doses of the MMR vaccine provide approximately 97% protection, and one dose provides 93% protection. But for the roughly 8% of kindergartners currently entering school without full documentation of MMR vaccination, and for the much larger population of older adults who may have missed doses or have waning immunity, the current environment carries real risk.
The U.S. is also approaching a historic threshold. The Pan American Health Organization will convene in November 2026 to formally evaluate whether the United States can retain the measles elimination status it has held since 2000. That determination depends on whether domestic sustained transmission has been occurring, and the 2025–2026 data make that question increasingly difficult to answer favorably.
What We Know So Far
The CDC's measles tracker, updated July 10, 2026, shows 2,231 confirmed measles cases reported by 42 jurisdictions, including 2,218 cases among U.S. residents and 13 cases among international visitors.
Thirty-two new outbreaks — defined as three or more linked cases — have been reported in 2026. Three deaths have been confirmed since the combined 2025-2026 outbreak period began: two unvaccinated children in Texas and one unvaccinated adult in New Mexico. These were the first measles deaths in the United States since 2015.
Utah has become the current national epicenter, with the state's Department of Health and Human Services confirming 499 measles cases in 2026, spread across 22 of the state's 29 counties. Utah's school vaccination rate for the 2024–2025 school year was 88.6% — well below the 95% threshold needed for herd immunity. The state legislature has been considering proposals that would further ease MMR exemption requirements, with changes potentially taking effect in mid-2026.
Florida has also recorded a high case count, with active outbreaks in multiple counties. Texas saw significant outbreak activity earlier in 2026, including the death of two unvaccinated children. South Carolina's 2025–2026 outbreak — the largest single measles outbreak since the disease was declared eliminated in 2000 — reached 997 total cases in Spartanburg County before being declared over in April.
Where the Risk Is Highest
The risk map for measles in 2026 closely tracks the map of low MMR vaccination coverage. Nationally, kindergarten MMR coverage has fallen from 95.2% during the 2019-2020 school year to 92.5% during 2024-2025 — below the 95% threshold needed to prevent sustained community spread, according to U.S. News and CDC data.
In some states, the gap is far larger. Utah's rate of 88.6% means approximately one in eight kindergartners enters school without full MMR documentation. Idaho's non-medical exemption rate sits at approximately 15.4% — meaning roughly one in seven kindergartners had an exemption. Arizona and Florida have also been flagged as falling below the herd immunity threshold.
The CDC's SchoolVaxView tool allows parents and local officials to look up vaccination coverage rates at the state and district level, which can reveal pockets of concentrated vulnerability that do not appear in statewide averages.
Major international airports and summer travel hubs present additional risk. Measles is a global disease, and travelers returning from countries with active outbreaks — including many in Europe, Asia, and Africa — can introduce new cases into under-vaccinated communities. New York City, Los Angeles, Chicago, and Miami, as high-traffic international entry points, warrant close attention from local health officials.
What Doctors and Experts Say
Dr. Graham Tse, a pediatrician and chief medical officer of MemorialCare Miller Children's and Women's Hospital in Long Beach, California, said the structural conditions for continued spread are firmly in place.
"With continued vaccine hesitancy, and the number of mistruths on social media and the community, and the confusing and conflicting recommendations coming from the FDA and CDC, there is every reason to suspect that more parents and guardians will decline routine childhood vaccinations, including measles vaccinations," Tse told Healthline. "It is likely that measles outbreaks will continue, and the numbers could rise in 2026."
Dr. Dave Chokshi, chair of the Common Health Coalition, noted the calculable cost of declining vaccination rates. "Vaccination is one of the most powerful investments we can make for the health of our children, but when we fail to maintain high vaccination rates, we all pay the price," Chokshi said in a statement, citing coalition research suggesting a 1% decline in childhood MMR vaccination rates could cause 17,000 measles cases, 4,000 hospitalizations, and 36 preventable deaths annually.
What the Evidence Shows — and What It Does Not
The data do not show that the MMR vaccine is failing. Two doses of MMR remain approximately 97% effective against measles, and the vaccine's safety profile is among the most extensively studied of any pharmaceutical product in history.
What the data do show is that vaccination coverage has eroded to the point where herd immunity — requiring approximately 95% coverage nationally — can no longer be reliably assumed. The concentration of unvaccinated individuals in specific communities, schools, and religious networks creates the conditions for large, sustained outbreaks even when statewide averages appear adequate.
Nonmedical exemptions — granted for philosophical or religious reasons rather than genuine medical contraindications — account for the vast majority of the gap between current coverage levels and the 95% threshold. The CDC's 2024-2025 school immunization data found that 3.6% of kindergartners had at least one vaccine exemption, up from 3.3% the prior year — representing approximately 138,000 children entering schools with inadequate protection.
Who Faces the Greatest Risk
Health officials say the groups most vulnerable to measles infection and complications include:
- Unvaccinated children, particularly those in communities with low coverage
- Infants under 12 months, who are too young to be vaccinated
- Adults who received only one dose and did not complete the two-dose series
- Adults who received vaccination before 1989, when dosing recommendations changed
- People with weakened immune systems, including chemotherapy patients
- Pregnant women (measles during pregnancy increases the risk of preterm birth and low birth weight)
- Anyone who has never been vaccinated
Symptoms and Warning Signs to Watch For
Measles symptoms typically appear 10 to 14 days after exposure. The illness progresses in stages:
Early symptoms (Days 1-4):
- High fever, often above 104°F
- Cough
- Runny nose
- Red, watery eyes (conjunctivitis)
- Koplik spots — tiny white spots inside the mouth — which appear shortly before the rash
Rash stage (Days 3-5 after symptom onset):
- A red, blotchy rash beginning at the hairline and spreading downward to the face, neck, and body
Complications can include ear infection, pneumonia, and encephalitis (brain swelling). Measles encephalitis occurs in approximately one of every 1,000 cases and can cause permanent brain damage. Children under 5 and adults over 20 face the highest risk of severe complications.
Anyone with these symptoms who may have been exposed — particularly in affected ZIP codes or communities with active outbreaks — should contact a health care provider before going to a medical facility, to avoid exposing others.
What You Can Do Now
- Verify your vaccination records. Two documented MMR doses are recommended for most adults born after 1957. Adults with uncertain vaccination history can safely receive a booster — the vaccine is safe even if previously vaccinated.
- Check your child's status before the fall 2026 school year. Students without documentation of two doses may be excluded from school during a measles exposure event.
- Look up your school or district using the CDC's SchoolVaxView tool to understand local vaccination coverage.
- Talk to your pediatrician about early MMR vaccination if you have an infant and plan to travel. The MMR can be given as early as 6 months in outbreak settings.
- Avoid waiting if symptoms appear. Call ahead before visiting any medical facility to avoid exposing other patients.
- Do not rely on social media for exemption guidance. Non-medical exemption decisions affect not only individual children but the broader community of infants, immunocompromised individuals, and others who cannot be vaccinated.
Cost and Access: What Patients Should Know
The MMR vaccine is covered at no cost under the Affordable Care Act's preventive services provisions for most private insurance plans and Medicaid. The Vaccines for Children (VFC) program provides free vaccines for uninsured and underinsured children at participating providers. Adults who need a low-cost MMR dose can contact their local health department.
There is no antiviral treatment for measles. Hospitalization for complications such as pneumonia or encephalitis can be costly, with treatment covered by most insurance plans and Medicare. The economic case for vaccination is clear: prevention consistently costs far less than treatment.
What Happens Next
The Pan American Health Organization will convene its Regional Verification Commission in November 2026 to formally assess whether the United States retains the measles elimination status it has held since 2000. If domestic sustained transmission is confirmed — a threshold the current outbreak data are approaching — the U.S. could become only the latest country to lose that designation, following Canada and several European nations.
Fall school reopenings in August and September historically drive additional measles transmission, particularly in districts with high exemption rates. The CDC is expected to continue publishing weekly case updates through the remainder of the year.
The Bottom Line
The 2026 measles crisis is not the result of a new strain, a vaccine failure, or an uncontrollable external force. It is the predictable outcome of declining MMR vaccination rates, rising nonmedical exemptions, and concentrated pockets of susceptibility in communities where misinformation about vaccine safety has taken hold. For families with children approaching school age, the most important action is straightforward: verify vaccination status and complete the two-dose series before fall. For everyone else, checking personal vaccination records is a reasonable precaution, particularly ahead of summer travel.
